P&O Ferries will scrap its "loss-making" route between Hull and Zeebrugge, Belgium due to a coronavirus-induced sharp drop in demand.
The ferry operator said it had to take "difficult action" due to the "extended impact of Covid-19."
The company also blamed the ongoing Brexit uncertainty were to blame.
The dropping of the route means the vessels Pride of Bruges and the Pride of York will be out of service.
The Pride of Bruges had operated momentarily, while the Pride of York has stopped operating since the pandemic.
The number of services between Dover and Calais is also expected to be reduced from six ferries to four, with voyages by the European Seaway and the Pride of Burgundy discontinued, putting 140 jobs at risk.
According to Darren Procter, national secretary for the Rail, Maritime, and Transport union, the Hull to Zeebrugge route had been challenging for many years and the pandemic had compounded the problem.
Proctor noted that the said scrapping of the route would impact Hull economically as travelers on these vessels use local amenities, such as having pub meals or stays in hotels.


SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion
CK Hutchison's Panama Ports Dispute Escalates as Arbitration Claims Surpass $2 Billion
AWS Bahrain Region Disrupted by Drone Activity Amid Middle East Conflict
NAB Plans to Cut 170 Jobs While Expanding Offshore Operations
Citi Names Eric Farina and Rob Cascarino to Lead Global Infrastructure Financing Group
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
SMIC Allegedly Supplies Chipmaking Tools to Iran's Military, U.S. Officials Warn
Rio Tinto's Resolution Copper Mine: U.S. Smelting Challenges and Global Operations Update
Air Canada Express Crash at LaGuardia: Controller Distracted by Prior Emergency
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Nintendo Switch 2 Production Cut as Holiday Sales Miss Targets
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Reflection AI Eyes $25 Billion Valuation in Massive $2.5 Billion Funding Round
Meta Ties Executive Pay to Aggressive Stock Price Targets in Major Retention Push
SpaceX IPO Filing Expected This Week as Valuation Could Surpass $75 Billion
Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025 



